Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: The effects on immediate-early gene expression in the rat prefrontal cortex

Neuropharmacology

Volumn 63, Issue 6, 2012, Pages 927-935

  Echeverry Alzate, Víctor ^a   Tuda Arízcun, María ^a   Bühler, Kora Mareen ^a   Santos, Ángel ^a   Giné, Elena ^a   Olmos, Pedro ^a,b   Gorriti, Miguel Ángel ^a   Huertas, Evelio ^a   Rodríguez De Fonseca, Fernando ^c   López Moreno, Jose Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CIEMAT   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Acamprosate; C fos; COX 2; Genetic expression; Naltrexone; Prefrontal

Indexed keywords

ACAMPROSATE; COCAINE; CYCLOOXYGENASE 2; NALTREXONE; PROTEIN C FOS;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; COX 2 GENE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMER1A GENE; HYPERACTIVITY; IMMEDIATE EARLY GENE; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NERVE FUNCTION; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PHENOTYPE; PREDICTIVE VALIDITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REWARD;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ANIMALS; CARRIER PROTEINS; COCAINE; CONDITIONING, OPERANT; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENES, FOS; GENES, IMMEDIATE-EARLY; MALE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SELF ADMINISTRATION; TAURINE;

EID: 84865248893     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.010     Document Type: Article

References (107)

1. K. Abernathy, L.J. Chandler, and J.J. Woodward Alcohol and the prefrontal cortex Int. Rev. Neurobiol. 91 2010 289 320
2. AEMPS: Spanish Agency for Medicines and Health Products. https://sinaem4.agemed.es/consaem/fichasTecnicas.do?metodo=detalleForm& version=new.
3. Y. Ago, S. Nakamura, A. Baba, and T. Matsuda Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice J. Pharmacol. Sci. 106 2008 15 21 (Pubitemid 351159064)
4. V. Aliane, S. Pérez, A. Nieoullon, J.M. Deniau, and M.L. Kemel Cocaine-induced stereotypy is linked to an imbalance between the medial prefrontal and sensorimotor circuits of the basal ganglia Eur. J. Neurosci. 30 2009 1269 1279
5. K. Antoniou, E. Kafetzopoulos, Z. Papadopoulou-Daifoti, T. Hyphantis, and M. Marselos d-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats Neurosci. Biobehav. Rev. 23 1998 189 196 (Pubitemid 29011621)
6. G. Aparicio-Gallego, S. Díaz Prado, P. Jiménez Fonseca, R. García Campelo, J. Cassinello Espinosa, and L.M. Antón Aparicio Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer Clin. Transl. Oncol. 9 2007 694 702
7. B.E. Bernier, L.R. Whitaker, and H. Morikawa Previous ethanol experience enhances synaptic plasticity of NMDA receptors in the ventral tegmental area J. Neurosci. 31 2011 5205 5212
8. M. Biały, and L. Kaczmarek c-Fos expression as a tool to search for the neurobiological base of the sexual behaviour of males Acta Neurobiol. Exp. (Wars) 56 1996 567 577 (Pubitemid 26179686)
9. P. Bienkowski, W. Kostowski, and E. Koros Ethanol-reinforced behaviour in the rat: effects of naltrexone Eur. J. Pharmacol. 374 1999 321 327 (Pubitemid 29313444)
10. H. Blumberg, and C. Ikeda Naltrexone, morphine and cocaine interactions in mice and rats J. Pharmacol. Exp. Ther. 206 1978 303 310 (Pubitemid 9041311)
11. C. Burattini, A.J. McGeehan, W.C. Griffin 3rd, J.T. Gass, J.R. Kinder, and P.H. Janak A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration Addict. Biol. 13 2008 70 79 (Pubitemid 351202144)
12. J. Cami, M. Farré, M.L. González, J. Segura, and R. de la Torre Cocaine metabolism in humans after use of alcohol. Clinical and research implications Recent Dev. Alcohol 14 1998 437 455
13. A.D. Corbett, G. Henderson, A.T. McKnight, and S.J. Paterson 75 years of opioid research: the exciting but vain quest for the Holy Grail Br. J. Pharmacol. 147 Suppl. 1 2006 153 162
14. C.L. Czachowski, and M.J. DeLory Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats Psychopharmacology (Berl.) 204 2009 335 348
15. C.M. Davis, and A.L. Riley The effects of cocaine preexposure on cocaine-induced taste aversion learning in Fischer and Lewis rat strains Pharmacol. Biochem. Behav. 87 2007 198 202 (Pubitemid 46860316)
16. C.V. Dayas, X. Liu, J.A. Simms, and F. Weiss Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone Biol. Psychiatry 61 2007 979 989 (Pubitemid 46482461)
17. A. Dobi, G.K. Seabold, C.H. Christensen, R. Bock, and V.A. Alvarez Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal J. Neurosci. 31 2011 1895 1904
18. Drugs@FDA: U.S. Food and Drug Administration, Approved Drug Products. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.
19. J. Feil, D. Sheppard, P.B. Fitzgerald, M. Yücel, D.I. Lubman, and J.L. Bradshaw Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control Neurosci. Biobehav. Rev. 35 2010 248 275
20. C.M. Ferrari, D.A. O'Connor, and A.L. Riley Cocaine-induced taste aversions: effects of route of administration Pharmacol. Biochem. Behav. 38 1991 267 271
21. R.K. Fuller, and E. Gordis Naltrexone treatment for alcohol dependence N. Engl. J. Med. 345 2001 1770 1771
22. J.C. Garbutt Efficacy and tolerability of naltrexone in the management of alcohol dependence Curr. Pharm. Des. 16 2010 2091 2097
23. M. Gossop, V. Manning, and G. Ridge Concurrent use of alcohol and cocaine: differences in patterns of use and problems among users of crack cocaine and cocaine powder Alcohol Alcohol 41 2006 121 125
24. A.J. Goudie, D.W. Dickins, and E.W. Thornton Cocaine-induced conditioned taste aversions in rats Pharmacol. Biochem. Behav. 8 1978 757 761 (Pubitemid 8395476)
25. B.F. Grant, and T.C. Harford Concurrent and simultaneous use of alcohol with cocaine: results of national survey Drug Alcohol Depend. 25 1990 97 104 (Pubitemid 20086961)
26. E.G. Guy, E. Choi, and W.E. Pratt Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues Behav. Brain Res. 219 2011 265 272
27. J. Häggkvist, C. Björkholm, P. Steensland, S. Lindholm, J. Franck, and B. Schilström Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat Addict. Biol. 16 2011 20 29
28. K.A. Harper, and A.J. Tyson-Capper Complexity of COX-2 gene regulation Biochem. Soc. Trans. 36 2008 543 545 (Pubitemid 351839376)
29. M.A. Hedaya, and W.J. Pan Effect of alcohol coadministration on the plasma and brain concentrations of cocaine in rats Drug Metab. Dispos. 25 1997 647 650 (Pubitemid 27213108)
30. D. Hersh, J.R. Van Kirk, and H.R. Kranzler Naltrexone treatment of comorbid alcohol and cocaine use disorders Psychopharmacology (Berl.) 139 1998 44 52 (Pubitemid 28416881)
31. A. Herz Endogenous opioid systems and alcohol addiction Psychopharmacology (Berl.) 129 1997 99 111 (Pubitemid 27033665)
32. C.J. Heyser, K. Moc, and G.F. Koob Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats Neuropsychopharmacology 28 2003 1463 1471 (Pubitemid 41070881)
33. T. Hillemacher, A. Heberlein, M.A. Muschler, S. Bleich, and H. Frieling Opioid modulators for alcohol dependence Expert Opin. Investig. Drugs 20 2011 1073 1086
34. C.L. Hubbell, and L.D. Reid Opioids modulate rats' intake of alcoholic beverages L.D. Reid, Opioids, Bulimia, and Alcohol Abuse and Alcoholism 1990 Springer-Verlag New York 145 174
35. D. Ji, N.W. Gilpin, H.N. Richardson, C.L. Rivier, and G.F. Koob Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats Behav. Pharmacol. 19 2008 1 12
36. B.A. Johnson A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence Expert Opin. Pharmacother. 7 2006 1065 1073 (Pubitemid 43949944)
37. B.A. Johnson Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings Biochem. Pharmacol. 75 2008 34 56 (Pubitemid 350235398)
38. B.A. Johnson Medication treatment of different types of alcoholism Am. J. Psychiatry 167 2010 630 639
39. B.A. Johnson, S.S. O'Malley, D.A. Ciraulo, J.D. Roache, R.A. Chambers, and O. Sarid-Segal Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects J. Clin. Psychopharmacol. 23 2003 281 293 (Pubitemid 36807795)
40. B.A. Johnson, N. Ait-Daoud, H.J. Aubin, W. Van Den Brink, R. Guzzetta, and J. Loewy A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence Alcohol Clin. Exp. Res. 28 2004 1356 1361 (Pubitemid 39238294)
41. S.N. Katner, S.M. Oster, Z.M. Ding, G.A. Deehan Jr., J.E. Toalston, and S.R. Hauser Alcohol-preferring (P) rats are more sensitive than Wistar rats to the reinforcing effects of cocaine self-administered directly into the nucleus accumbens shell Pharmacol. Biochem. Behav. 99 2011 688 695
42. F. Kiefer, and K. Mann Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy Curr. Pharm. Des. 16 2010 2098 2102
43. F. Kiefer, and K. Wiedemann Combined therapy: what does acamprosate and naltrexone combination tell us? Alcohol Alcohol 39 2004 542 547 (Pubitemid 39534539)
44. S.G. Kim, B.D. Han, J.M. Park, M.J. Kim, and M.F. Stromberg Effect of the combination of naltrexone and acamprosate on alcohol intake in mice Psychiatry Clin. Neurosci. 58 2004 30 36 (Pubitemid 38200368)
45. G.F. Koob, A.J. Roberts, B.L. Kieffer, C.J. Heyser, S.N. Katner, and R. Ciccocioppo Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology Recent Dev. Alcohol 16 2003 263 281
46. T.R. Kosten, and T.P. George The neurobiology of opioid dependence: implications for treatment Sci. Pract. Perspect. 1 2002 13 20
47. H.R. Kranzler, L.B. Montejano, J.J. Stephenson, S. Wang, and D.R. Gastfriend Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population Alcohol Clin. Exp. Res. 34 2010 1090 1097
48. S. Kubik, T. Miyashita, and J.F. Guzowski Using immediate-early genes to map hippocampal subregional functions Learn. Memory 14 2007 758 770 (Pubitemid 350172774)
49. V. Kulaga, S. Shor, and G. Koren Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder Alcohol 44 2010 615 621
50. S.C. Laizure, T. Mandrell, N.M. Gades, and R.B. Parker Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases Drug Metab. Dispos. 31 2003 16 20 (Pubitemid 36735253)
51. A. Lanahan, and P. Worley Immediate-early genes and synaptic function Neurobiol. Learn. Mem. 70 1998 37 43 (Pubitemid 28455580)
52. M.J. Landry An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite J. Psychoact. Drugs 24 1992 273 276
53. J. Li, Y. Cheng, W. Bian, X. Liu, C. Zhang, and J.H. Ye Region-specific induction of FosB/ΔFosB by voluntary alcohol intake: effects of naltrexone Alcohol Clin. Exp. Res. 34 2010 1742 1750
54. J. Littleton Acamprosate in alcohol dependence: how does it work? Addiction 90 1995 1179 1188
55. J.A. López-Moreno, J.M. Trigo-Díaz, F. Rodríguez de Fonseca, G. González Cuevas, R. Gómez de Heras, and I. Crespo Galán Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement Neuropharmacology 47 2004 1036 1044 (Pubitemid 39535842)
56. J.A. López-Moreno, G. González-Cuevas, G. Moreno, and M. Navarro The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction Addict. Biol. 13 2008 160 187 (Pubitemid 351692981)
57. J. Lucena, M. Blanco, C. Jurado, A. Rico, M. Salguero, and R. Vazquez Cocaine-related sudden death: a prospective investigation in south-west Spain Eur. Heart J. 31 2010 318 329
58. C. Lüscher, and R.C. Malenka Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling Neuron 69 2011 650 663
59. P. Mannelli, K.S. Peindl, and L.T. Wu Pharmacological enhancement of naltrexone treatment for opioid dependence: a review Subst. Abuse Rehabil. 2 2011 113 123
60. P.W. Marinelli, D. Funk, W. Juzytsch, Z. Li, and A.D. Lê Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression Eur. J. Neurosci. 26 2007 2815 2823 (Pubitemid 350115512)
61. B.J. Mason Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment Eur. Neuropsychopharmacol. 13 2003 469 475 (Pubitemid 37433967)
62. B.J. Mason Acamprosate in the treatment of alcohol dependence Expert Opin. Pharmacother. 6 2005 2103 2115 (Pubitemid 41600586)
63. B.J. Mattson, E. Koya, D.E. Simmons, T.B. Mitchell, A. Berkow, and H.S. Crombag Context-specific sensitization of cocaine-induced locomotor activity and associated neuronal ensembles in rat nucleus accumbens Eur. J. Neurosci. 27 2008 202 212
64. P. Mierzejewski, A. Rogowski, R. Stefanski, S. Goldberg, W. Kostowski, and P. Bienkowski Ethanol-reinforced behaviour predicts acquisition but not extinction of cocaine self-administration in the rat Alcohol Alcohol 38 2003 543 549 (Pubitemid 37455851)
65. N.S. Miller, R.B. Millman, and S. Keskinen The diagnosis of alcohol, cocaine, and other drug dependence in an inpatient treatment population J. Subst. Abuse Treat. 6 1989 37 40 (Pubitemid 19106194)
66. J.I. Morgan, and T. Curran Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun Annu. Rev. Neurosci. 14 1991 421 451
67. A.A. Nanji, L. Miao, P. Thomas, A. Rahemtulla, S. Khwaja, and S. Zhao Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat Gastroenterology 112 1997 943 951 (Pubitemid 27113821)
68. E.J. Nestler Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2, 119-128 Erratum in: Nat. Rev. Neurosci. 2 2001 215
69. E.J. Nestler The neurobiology of cocaine addiction Sci. Pract. Perspect. 3 2005 4 10
70. C.P. O'Brien, L.A. Volpicelli, and J.R. Volpicelli Naltrexone in the treatment of alcoholism: a clinical review Alcohol 13 1996 35 39 (Pubitemid 26061201)
71. A.D. O'Connor, D.E. Rusyniak, and A. Bruno Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse Med. Clin. North Am. 89 2005 1343 1358 (Pubitemid 41446574)
72. O.E. Odeleye, R.R. Watson, C.D. Eskelson, and D. Earnest Enhancement of cocaine-induced hepatotoxicity by ethanol Drug Alcohol Depend. 31 1993 253 263 (Pubitemid 23093394)
73. D.W. Oslin, H.M. Pettinati, J.R. Volpicelli, A.L. Wolf, K.M. Kampman, and C.P. O'Brien The effects of naltrexone on alcohol and cocaine use in dually addicted patients J. Subst. Abuse Treat. 16 1999 163 167 (Pubitemid 29066428)
74. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press San Diego
75. H.M. Pettinati, K.M. Kampman, K.G. Lynch, J.J. Suh, C.A. Dackis, and D.W. Oslin Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence J. Subst. Abuse Treat. 34 2008 378 390 (Pubitemid 351609292)
76. H.M. Pettinati, K.M. Kampman, K.G. Lynch, H. Xie, C. Dackis, and A.R. Rabinowitz A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence Addict. Behav. 33 2008 651 667
77. T. Randall Cocaine, alcohol mix in body to form even longer lasting, more lethal drug JAMA 267 1992 1043 1044
78. S. Rösner, A. Hackl-Herrwerth, S. Leucht, S. Vecchi, M. Srisurapanont, and M. Soyka Opioid antagonists for alcohol dependence Cochrane Database Syst. Rev. 8 2010 CD001867
79. L. Ross, and D.W. Schaal Time of supplemental feeding alters the effects of cocaine on lever pressing of rats J. Exp. Anal. Behav. 77 2002 199 208
80. G. Rubio, J. Manzanares, M. Jiménez, R. Rodríguez- Jiménez, I. Martinez, and M.M. Iribarren Use of cocaine by heavy drinkers increases vulnerability to developing alcohol dependence: a 4-year follow-up study J. Clin. Psychiatry 69 2008 563 570 (Pubitemid 351792330)
81. H.J. Sable, S.L. White, and R.E. Steinpreis Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine Alcohol 33 2004 51 61 (Pubitemid 39195015)
82. M.D. Schechter Cocaethylene produces conditioned place preference in rats Pharmacol. Biochem. Behav. 51 1995 549 552
83. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat. Protoc. 3 2008 1101 1108 (Pubitemid 351818697)
84. J.M. Schmitz, A.L. Stotts, S.L. Sayre, K.A. DeLaune, and J. Grabowski Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy Am. J. Addict. 13 2004 333 341 (Pubitemid 39244792)
85. J.M. Schmitz, J.A. Lindsay, C.E. Green, D.V. Herin, A.L. Stotts, and F.G. Moeller High-dose naltrexone therapy for cocaine-alcohol dependence Am. J. Addict. 18 2009 356 362
86. A. Simonyi, D. Woods, A.Y. Sun, and G.Y. Sun Grape polyphenols inhibit chronic ethanol-induced COX-2 mRNA expression in rat brain Alcohol Clin. Exp. Res. 26 2002 352 357 (Pubitemid 34225840)
87. M.A. Smith, J.L. Greene-Naples, J.N. Felder, J.C. Iordanou, M.A. Lyle, and K.L. Walker The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine J. Pharmacol. Exp. Ther. 330 2009 476 486
88. M. Soyka, and S. Rösner Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review Curr. Drug Abuse Rev. 1 2008 280 291
89. R. Spanagel, and W. Zieglgänsberger Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes Trends Pharmacol. Sci. 18 1997 54 59 (Pubitemid 27115855)
90. M.F. Stromberg, and S.A. Mackler The effect of cocaine on the expression of motor activity and conditioned place preference in high and low alcohol-preferring Wistar rats Pharmacol. Biochem. Behav. 82 2005 314 319 (Pubitemid 41727942)
91. M.F. Stromberg, M. Casale, L. Volpicelli, J.R. Volpicelli, and C.P. O'Brien A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat Alcohol 15 1998 281 289 (Pubitemid 28205097)
92. M.F. Stromberg, S.A. Mackler, J.R. Volpicelli, and C.P. O'Brien Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption Alcohol 23 2001 109 116 (Pubitemid 32377750)
93. M.F. Stromberg, T. Sengpiel, S.A. Mackler, J.R. Volpicelli, C.P. O'Brien, and W.H. Vogel Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat Alcohol 28 2002 169 179 (Pubitemid 36120484)
94. J.J. Suh, H.M. Pettinati, K.M. Kampman, and C.P. O'Brien Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence Am. J. Addict. 17 2008 463 468
95. S.L. Vallés, A.M. Blanco, M. Pascual, and C. Guerri Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes Brain Pathol. 14 2004 365 371 (Pubitemid 39524965)
96. F. van Haaren, and K. Anderson Effects of cocaine on fixed-interval behavior and schedule-induced alcohol consumption in male and female rats Pharmacol. Biochem. Behav. 47 1994 997 1002 (Pubitemid 24119916)
97. V.W. Vanek, H.I. Dickey-White, S.A. Signs, M.D. Schechter, T. Buss, and A.T. Kulics Concurrent use of cocaine and alcohol by patients treated in the emergency department Ann. Emerg. Med. 28 1996 508 514 (Pubitemid 26367411)
98. V. Vengeliene, E. Celerier, L. Chaskiel, F. Penzo, and R. Spanagel Compulsive alcohol drinking in rodents Addict. Biol. 14 2009 384 396
99. B.J. Venton, A.T. Seipel, P.E. Phillips, W.C. Wetsel, D. Gitler, and P. Greengard Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool J. Neurosci. 26 2006 3206 3209
100. K. Verebey, J. Volavka, S.J. Mulé, and R.B. Resnick Naltrexone: disposition, metabolism, and effects after acute and chronic dosing Clin. Pharmacol. Ther. 20 1976 315 328
101. M.P. Vroegop, E.J. Franssen, P.H. van der Voort, T.N. van den Berg, R.J. Langeweg, and C. Kramers The emergency care of cocaine intoxications Neth. J. Med. 67 2009 122 126
102. B.M. Walker, and G.F. Koob Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence Neuropsychopharmacology 33 2008 643 652
103. B.M. Walker, E.P. Zorrilla, and G.F. Koob Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats Addict. Biol. 16 2011 116 119
104. S.R. Weiss, R.M. Post, A. Pert, R. Woodward, and D. Murman Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression Pharmacol. Biochem. Behav. 34 1989 655 661 (Pubitemid 20025110)
105. K.L. Williams, and C.L. Broadbridge Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection Alcohol 43 2009 119 126
106. World Health Organization Global Information System on Alcohol and Health (GISAH) 2011 http://apps.who.int/ghodata/?theme=GISAH
107. J. Yu, D. Halder, M.N. Baek, N.D. Das, M.R. Choi, and D.Y. Oh Changes in the expression of transthyretin and protein kinase Cγ genes in the prefrontal cortex in response to naltrexone Neurosci. Lett. 488 2011 288 293